22/11/24

Newsletter Cerba November 22nd - Tests : new deadlines

30/10/24

Our Customer Service will be closed the 1st and the 11th of November

21/10/24

Newsletter Cerba October 18th - Tests : new deadlines

11/10/24

Newsletter Cerba October 11th - Tests : new deadlines

16/09/24

Newsletter Cerba September 6th - Tests : new deadlines

21/08/24

Newsletter Cerba August 21st - Tests : new deadlines

13/08/24

Newsletter Cerba August 13th - Tests : new turnaround times and public holidays

12/08/24

Newsletter Cerba July 26th - Tests : new deadlines

01/08/24

Newsletter Cerba July 26th - Tests : new deadlines

23/07/24

Newsletter Cerba July 19th - Tests : new turnaround times

15/07/24

Newsletter Cerba July 12th - Tests new delivery schedule

09/07/24

SCREENING FOR FETAL TRISOMY 21 : SERUM MARKERS CHANGE IN PREANALYTICAL CONDITIONS

09/07/24

Newsletter Cerba July 5th - Tests : New delivery schedule and evolutions

24/06/24

New delais and evolutions

17/06/24

New delais and evolutions

17/06/24

New delais and evolutions

11/06/24

Blood serotonins: 2 frozen tubes

30/05/24

23rd of May 2024 Cerba Newsletter

22/05/24

2024 Cerba Newsletter

22/05/24

2024 Cerba Newsletter

29/04/24

The Cerba Newsletter is Evolving in 2024

29/04/24

MOVES IN PROGRESS AND DELAYS

18/04/24

MOVES IN PROGRESS AND DELAYS

21/03/24

Delays and return to normal

12/03/24

The diagnosis of GLUT1 deficiency syndrome

08/03/24

Test : Delay and return to normal

06/03/24

Delay and return to normal

26/02/24

General Information - Stages of the Move

20/02/24

Moving and new deadlines

20/02/24

Moving and new deadlines

09/02/24

Test : Delay and return to normal

23/01/24

An environmentally-friendly site

19/01/24

Predictix® : Next-generation test for prescribing antidepressants

17/01/24

Dosage of 2nd generation antidepressants: a new exam

21/12/23

THE NEW FREPILLON SITE WILL HOUSE 3 ENTITIES

18/12/23

MAY BANK HOLIDAYS: SAMPLING AND OPENING HOURS

15/12/23

Prenatal: fetal sex determination (circulating DNA)

11/12/23

A NEW CHAPTER BEGINS FOR THE CERBA LABORATORY

09/11/23

FOR SOME EXAMINATIONS : NO SAMPLES FROM 9 NOVEMBER (BANK HOLIDAY IN FRANCE : NOVEMBER 11)

20/07/23

Endocrine disruptors, New information on treatment in 2023

04/07/23

21/06/23

ALDOLASE reagent shortage

16/06/23

URINARY METANEPHRINES TEMPORARY EXTENSION OF DELIVERY TIME

26/05/23

Important notice : medium transport for NIPT

10/05/23

Anti-Platelet AC test - Stop

17/04/23

New Site Cerba Oncology

13/04/23

B6 VITAMIN : TECHNICAL CHANGE

12/04/23

NEW TEST : OPTICAL GENOME MAPPING

28/03/23

Midwives Days 2023

20/03/23

Next Cerba Live Session on Thursday 23 March: Analysis of human genomes by optical mapping

13/02/23

Lymphocytes T (T3/T4/T8) reagents

10/10/22

The Customer Relation Desk : Autumn opening hours

30/06/22

Customer service : summer holidays opening hours

20/05/22

Customer service : closed the 26th of May

18/03/22

NIPD, free circulating DNA tests - supplies back in stock

26/01/22

05/07/21

IT Security Incident

11/05/21

New information on Myelogram bone marrow sampling

16/12/20

New: Cerba laboratory now proposes a range of tests for the diagnosis of lysosomal storage diseases.

28/10/20

Dépistage de la pré-éclampsie : de la clinique au laboratoire

22/06/20

New: recombinant peach allergen, rPru p 7 is now available

15/04/20

Change of technique and sample nature for Aldosterone measurement

27/11/19

Attention: new sampling recommendations and pre-analytical conditions for the total IgE in tears

17/09/19

Arrêt du test de l’hydroxyproline urinaire

11/01/19

Laboratoire CERBA enters into licensing agreement with IntegraGen for the commercialization of miR-31-3p tumor expression test in France, Benelux, Middle East and Africa

11/01/19

Laboratoire CERBA and PATHOQUEST announce partnership making the iDTECT™ BLOOD test available for clinical use in the precision diagnosis of infectious diseases

11/01/19

METAglut1, A NEW DIAGNOSTIC TEST FOR THE GLUT1 DEFICIENCY SYNDROME

11/01/19

Cerba HealthCare announces the launch of its endowment funds: « Institut Cerba »

11/01/19

Licensing agreement between Cerba and IntegraGen for the commercialization...

11/01/19

New blood test to diagnose cancers due to HPV.

Anti-Platelet AC test - Stop

Dear colleague,

The anti-platelet assay (MACE technique of first intention in the context of unexplained thrombocytopenia of peripheral origin) will no longer be performed at the CERBA laboratory as of April 29, 2023.
It will also not be transmitted. Any request for anti-platelet Ac will be refused.

We remain at your disposal for any questions you may have.

We remain at your disposal for any information,

The Cerba Customer Relations Department
intgb@lab-cerba.com